Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Change in macrophages activation in tumour from GSKi pre-treated 4T1 cells 8 days or 14 post fatpad injection in Balb/c mice

ABSTRACT: Change in macrophages activation in tumour from GSKi pre-treated 4T1 cells 8 days or 14 post fatpad injection in Balb/c mice

PROVIDER: PRJNA858060 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR20105147.fastq.gz	Fastqsanger.gz
	SRR20105148.fastq.gz	Fastqsanger.gz
	SRR20105149.fastq.gz	Fastqsanger.gz
	SRR20105150.fastq.gz	Fastqsanger.gz
	SRR20105151.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 14

Similar Datasets

Change in Fibroblast activation in tumour from GSKi pre-treated 4T1 cells 8 days post fatpad injection in Balb/c mice

Project description:Change in Fibroblast activation in tumour from GSKi pre-treated 4T1 cells 8 days post fatpad injection in Balb/c mice

| PRJNA858058 | ENA

Change in Fibroblast activation in tumour from GSKi pre-treated 4T1 cells 8 days post fatpad injection in Balb/c mice

Project description:Cancer infiltrating fibroablas from 4T1 cells pretreated with DMSO or GSKi (5 μM of GSK269962A (Axon, 1167)) for five days

2022-07-13 | GSE208049 | GEO

Change in macrophages activation in tumour from GSKi pre-treated 4T1 cells 8 days or 14 post fatpad injection in Balb/c mice

Project description:Cancer infiltrating macrophages from 4T1 cells pretreated with DMSO or GSKi (5 μM of GSK269962A (Axon, 1167)) for five days

2022-07-13 | GSE208050 | GEO

Gene expression profile at single cell level of immune cells from STING-NP treated 4T1 BALB/c tumors

Project description:scRNA-seq was performed on immune cells isolated from 4T1 BALB/c tumors to investigate their response to various treatments.

2025-03-05 | GSE226922 | GEO

Gene expression profiling of 4T1 cells isolated from primary tumour or from spontaneous metastases sites

Project description:Differential gene expression in 4T1 mouse mammary tumour cells isolated from primary tumour or metastatic sites.

2019-01-10 | GSE110101 | GEO

Skin biopsies from footpad of Balb/c mice after LPS injection

Project description:Skin biopsies from footpad of Balb/c mice after LPS injection. This protocol was performed to predict an inflammation model.

2019-03-22 | MSV000083622 | MassIVE

DNA accessibility in CD8+ tumour-infiltrating T cells treated with Phenelzine.

Project description:Phenelzine treatments were conducted in tumour-bearing Balb/c mice and then 4T1 tumours were acquired. CD8+ tumour-infiltrating T cells were positively selected by using mouse CD8a (Ly-2) microbeads and isolated by autoMACS Separator with recommended programs. Then isolated CD8 T cells were stimulated by PMA and Ionomycin. Global ATAC-seq analysis was performed to identify the dynamic changes in chromatin accessibility of tumour-filtrating CD8 T cells after phenelzine treatment.

2018-12-05 | GSE107724 | GEO

4T1 mouse tumour single cell dataset for virtual reality exploration

Project description:50,000 cells were injected orthotopically into the inguinal fat pad of a Nod-Scid-Gamma (NSG) immuno-compromised mouse. Injected cells were 80% unlabelled 4T1 cells (parental population), and 20% ZsGreen-labelled 4T1-T cells (clone isolated in Wagenblast et Al, Nature, 2015). Tumour were allowed to develop for 20 days, and then collected during necropsy. Disaggegated cells were processed through the 10X genomics Single Cell 3' gene expression pipeline. This data is intended as an example dataset for a novel virtual reality viewer for single-cell data described in Bressan et Al, Nat. Cancer, 2021 (submitted)

2022-06-14 | GSE178069 | GEO

Transcription profiling of mouse BALB/c strain animals injected with breast cancer 4T1-derived cells to investigate the role of epithelial to mesenchymal transition (EMT) in spontaneous breast cancer metastasis

Project description:Epithelial-mesenchymal transition (EMT) has been linked to cancer progression and metastatic propensity. The 4T1 tumor is a clinically relevant model of spontaneous breast cancer metastasis. Here we characterize 4T1-derived cell lines for EMT, in vitro invasiveness and in vivo metastatic ability. Contrary to expectations, the 67NR cells, which form primary tumors but fail to metastasize, express vimentin and N-cadherin, but not E-cadherin. 4T1 cells, however, express E-cadherin, are highly migratory and invasive, and metastasize to multiple sites. The 66cl4 metastatic cells display mixed epithelial and mesenchymal markers, but are less migratory and invasive than 67NR cells. These findings demonstrate that the metastatic ability of breast cancer cells does not correlate with genotypic and phenotypic properties of EMT per se, and suggest that other processes may govern metastatic capability. Gene expression analysis also has not identified differences in EMT markers, but has identified several candidate genes that may influence metastatic ability. Experiment Overall Design: Female BALB/c mice were injected with 1x10^6 viable cells (3 mice with 4T1/CMVLUC, 3 mice with 66cl4/CMVLUC, and 3 mice with 67NR/CMVLUC) into the right fourth mammary gland. 15 days after injection primary tumors were excised, and total RNA for microarray hybridization was isolated from the tumor part of laser capture microdissected sections.

2009-03-07 | E-GEOD-11259 | biostudies-arrayexpress

Next Generation Sequencing of tumor tissue (4T1 cell) of BALB/c

Project description:Next Generation Sequencing of tumor tissue (4T1 cell) of BALB/c

| PRJNA776639 | ENA